Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

Phase 3

Withdrawn

• Conditions: Post-surgical Inflammation

• Registration Number: NCT00404937
• Lead Sponsor: Alcon Research

Brief Summary

The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-11-28
• Study First Submitted QC: 2006-11-28
• Study First Posted: 2006-11-29
• Study Start: 2006-12
• Primary Completion: 2006-12
• Study Completion: 2006-12
• Status Verified: 2007-09
• Last Update Submitted: 2012-03-03
• Last Update Posted: 2012-03-06

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients scheduled for cataract extraction

Exclusion Criteria

• Under 18 years

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Anterior chamber inflammation

Secondary Outcome Measures

Name	Time	Method
Aqueous cells and flare
ocular pain
physician's impression of infection
frequency of treatment failures